Biosimulation Market Estimated To Reach $1.2 Billion By 2017: MarketsandMarkets
The process of identifying a drug molecule and developing it into a potential therapeutic has moved from the lab to the computers. Many softwares and models are being widely used in drug discovery and development process. Even though pharmaceutical companies have integrated biosimulation technology in …